Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

KORU Medical Systems Debt to Equity Ratio 2010-2025 | KRMD

Current and historical debt to equity ratio values for KORU Medical Systems (KRMD) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. KORU Medical Systems debt/equity for the three months ending March 31, 2025 was 0.01.
  
KORU Medical Systems Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2025-03-31 $0.01B $0.02B 0.67
2024-12-31 $0.01B $0.02B 0.62
2024-09-30 $0.01B $0.02B 0.55
2024-06-30 $0.01B $0.02B 0.46
2024-03-31 $0.01B $0.02B 0.44
2023-12-31 $0.01B $0.02B 0.40
2023-09-30 $0.01B $0.03B 0.29
2023-06-30 $0.01B $0.03B 0.28
2023-03-31 $0.01B $0.03B 0.28
2022-12-31 $0.01B $0.03B 0.35
2022-09-30 $0.01B $0.03B 0.31
2022-06-30 $0.01B $0.03B 0.30
2022-03-31 $0.01B $0.04B 0.25
2021-12-31 $0.01B $0.04B 0.13
2021-09-30 $0.01B $0.04B 0.12
2021-06-30 $0.00B $0.04B 0.09
2021-03-31 $0.01B $0.04B 0.12
2020-12-31 $0.00B $0.04B 0.10
2020-09-30 $0.01B $0.04B 0.14
2020-06-30 $0.01B $0.04B 0.22
2020-03-31 $0.00B $0.01B 0.37
2019-12-31 $0.00B $0.01B 0.24
2019-09-30 $0.00B $0.01B 0.25
2019-06-30 $0.00B $0.01B 0.24
2019-03-31 $0.00B $0.01B 0.26
2018-12-31 $0.00B $0.01B 0.18
2018-09-30 $0.00B $0.01B 0.16
2018-06-30 $0.00B $0.01B 0.18
2018-03-31 $0.00B $0.01B 0.15
2017-12-31 $0.00B $0.01B 0.21
2017-09-30 $0.00B $0.01B 0.17
2017-06-30 $0.00B $0.01B 0.14
2017-03-31 $0.00B 0.00
2017-02-28 $0.00B $0.01B 0.22
2016-11-30 $0.00B $0.01B 0.26
2016-09-30 $0.00B 0.00
2016-08-31 $0.00B $0.01B 0.23
2016-06-30 $0.00B 0.00
2016-05-31 $0.00B $0.01B 0.20
2016-02-29 $0.00B $0.01B 0.18
2015-11-30 $0.00B $0.01B 0.21
2015-08-31 $0.00B $0.01B 0.18
2015-05-31 $0.00B $0.01B 0.20
2015-02-28 $0.00B $0.01B 0.16
2014-11-30 $0.00B $0.01B 0.23
2014-08-31 $0.00B $0.01B 0.20
2014-05-31 $0.00B $0.01B 0.24
2014-02-28 $0.00B $0.01B 0.20
2013-11-30 $0.00B $0.01B 0.17
2013-08-31 $0.00B $0.01B 0.18
2013-05-31 $0.00B $0.00B 0.17
2013-02-28 $0.00B $0.00B 0.28
2012-11-30 $0.00B $0.00B 0.32
2012-08-31 $0.00B $0.00B 0.31
2012-05-31 $0.00B $0.00B 0.32
2012-03-31 $0.00B 0.00
2012-02-29 $0.00B $0.00B 0.35
2011-12-31 $0.00B $0.00B 0.35
2011-11-30 $0.00B 0.00
2011-09-30 $0.00B $0.00B 0.33
2011-08-31 $0.00B 0.00
2011-06-30 $0.00B $0.00B 0.39
2011-05-31 $0.00B 0.00
2011-03-31 $0.00B $0.00B 0.38
2011-02-28 $0.00B 0.00
2010-12-31 $0.00B $0.00B 0.45
2010-09-30 $0.00B $0.00B 0.49
2010-06-30 $0.00B $0.00B 0.70
2010-03-31 $0.00B $0.00B 0.77
2009-12-31 $0.00B $0.00B 1.31
2009-09-30 $0.00B $0.00B 1.37
2009-06-30 $0.00B $0.00B 1.92
2009-03-31 $0.00B $0.00B 2.29
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.131B $0.034B
KORU Medical Systems Inc. is a medical technology company. It focused on development, manufacturing and commercialization of patient-centric large volume subcutaneous infusion solutions. KORU Medical Systems Inc., formerly known as REPRO MEDSYSTEM, is based in MAHWAH, N.J.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $46.328B 59.20
Hims & Hers Health (HIMS) United States $12.250B 127.28
Tempus AI (TEM) United States $10.726B 0.00
IRhythm Technologies (IRTC) United States $4.629B 0.00
Inspire Medical Systems (INSP) United States $4.081B 63.76
Hinge Health (HNGE) United States $3.147B 0.00
Privia Health (PRVA) United States $2.800B 191.42
Enovis (ENOV) United States $1.753B 9.77
Schrodinger (SDGR) United States $1.680B 0.00
Clover Health Investments (CLOV) United States $1.578B 0.00
Phreesia (PHR) United States $1.534B 0.00
Omnicell (OMCL) United States $1.453B 25.64
Azenta (AZTA) United States $1.298B 60.34
10x Genomics (TXG) United States $1.122B 0.00
Fulgent Genetics (FLGT) United States $0.644B 0.00
Claritev (CTEV) United States $0.618B 0.00
Butterfly Network (BFLY) United States $0.584B 0.00
Talkspace (TALK) United States $0.571B 170.50
Veradigm (MDRX) United States $0.466B 0.00
Standard BioTools (LAB) United States $0.406B 0.00
TruBridge (TBRG) United States $0.357B 793.00
Outset Medical (OM) United States $0.344B 0.00
Health Catalyst (HCAT) United States $0.281B 0.00
Nyxoah SA (NYXH) Belgium $0.267B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.202B 0.00
Pulmonx (LUNG) United States $0.128B 0.00
EUDA Health Holdings (EUDA) Singapore $0.123B 0.00
American Well (AMWL) United States $0.108B 0.00
MDxHealth SA (MDXH) Belgium $0.103B 0.00
CareCloud (CCLD) United States $0.092B 3.50
111 (YI) China $0.070B 0.00
HeartBeam (BEAT) United States $0.061B 0.00
P3 Health Partners (PIII) United States $0.049B 0.00
Zepp Health (ZEPP) Netherlands $0.036B 0.00
Zhongchao (ZCMD) China $0.028B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.026B 0.00
Streamline Health Solutions (STRM) United States $0.022B 0.00
Bullfrog AI Holdings (BFRG) United States $0.016B 0.00
Precipio (PRPO) United States $0.016B 0.00
MSP Recovery (MSPR) United States $0.011B 0.00
Strata Skin Sciences (SSKN) United States $0.010B 0.00
Predictive Oncology (POAI) United States $0.009B 0.00
Movano (MOVE) United States $0.005B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
Evaxion - (EVAX) Denmark $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
Healthcare Triangle (HCTI) United States $0.000B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00